Takara spins off biotech unit
Tuesday, 02 April, 2002
Japanese liquor maker Takara Shuzo has stepped up its push to make a name for itself in the biotechnology sector by separating its bio-related activities into a new company.
The split, which was completed on Monday (April 1) as the new Japanese fiscal year began, has resulted in the formation of two companies, Takara Shuzo Co Ltd and Takara Biomedical Co Ltd, under a single holding company, Takara Holdings Inc.
Otsu, Japan based Takara Biomedical includes Dragon Genomics, a genome analysis center formed last year in western Japan.
$96m RNA Research and Manufacturing Facility opens in NSW
The new 4500 sqm RNA Research and Manufacturing Facility within the Macquarie University...
Cartherics and Catalent announce enhanced partnership
To support immune cell therapy products for the treatment of cancer and endometriosis, Australian...
Alliance seeks to boost regional capacity in clinical trials
Launched this week, the Barwon Health–Deakin University Clinical Trials Alliance is...
